Drug-maker Ranbaxy Laboratories declared on 20 December 2010 that it South Africa-based joint venture, Sonke Pharmaceutical bagged a 913.5 million rand (about Rs 605 crore) order from South African government. Ranbaxy’s joint venture won the contract from the South Africa government for supply of drugs for prevention and treatment of AIDS. The 913.5 million rand order bagged by Sonke is a part of a 4.28 billion rand national anti-retroviral (ARV) tender floated by the South African government. The SA government approved of the implementation to scale up the HIV and AIDS prevention and treatment programme introduced by the South African Health Minister, Dr Aaron Motsoaledi. The medicines will be manufactured in South Africa and at Ranbaxy facilities in India. Sonke Pharmaceuticals which is a joint venture between Ranbaxy Pharmaceuticals and Community Investment Holding, is the second largest local supplier of generic ARV medication in South Africa.
Ranbaxy JV Won Contract from SA Government
Ranbaxy Laboratories, Sonke Pharmaceutical bagged a 913.5 million from South African government.
.jpg){kind=logo}
Your career begins here! At Jagranjosh.com, our vision is to enable the youth to make informed life decisions, and our mission is to create credible and actionable content that answers questions or solves problems for India’s share of Next Billion Users. As India’s leading education and career guidance platform, we connect the dots for students, guiding them through every step of their journey—from excelling in school exams, board exams, and entrance tests to securing competitive jobs and building essential skills for their profession. With our deep expertise in exams and education, along with accurate information, expert insights, and interactive tools, we bridge the gap between education and opportunity, empowering students to confidently achieve their goals.
-1767014248507.jpg)
-1767005686052.jpg)
Comments
All Comments (0)
Join the conversation